Literature DB >> 7925749

Changes of ovarian hormonal function with aging.

H L Judd1, N Fournet.   

Abstract

Striking changes of ovarian function occur with aging. These changes begin subtly with reductions of fecundability being observed after age 25. The transition from reproductive to postreproductive life is characterized by menstrual irregularity including anovulation, or short luteal phases. The most prominent hormonal changes at the menopause are drastic reductions of estradiol and progesterone secretion by the ovary, reflecting the cessation of folliculogenesis and ovulation. Elevations of gonadotropins and reduction of inhibin levels also reflect the loss of folliculogenesis and ovulation. There are accompanying decreases of ovarian androgen secretion; however, the postmenopausal gonad directly secretes more testosterone after, than before, the menopause.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925749     DOI: 10.1016/0531-5565(94)90008-6

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  7 in total

1.  Hysterectomy status, estrogen use and quality of life in older women: the Rancho Bernardo study.

Authors:  Donna Kritz-Silverstein; Denise G Von Muhlen; Theodore G Ganiats; Elizabeth Barrett-Connor
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

2.  Turner's syndrome mosaicism 45X/47XXX: an interesting natural history.

Authors:  L Tauchmanovà; R Rossi; M Pulcrano; L Tarantino; C Baldi; G Lombardi
Journal:  J Endocrinol Invest       Date:  2001-11       Impact factor: 4.256

Review 3.  Estrogens, episodic memory, and Alzheimer's disease: a critical update.

Authors:  Victor W Henderson
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

Review 4.  The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.

Authors:  Andrea J Rapkin; Judith A Mikacich; Babak Moatakef-Imani; Natalie Rasgon
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 5.  Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.

Authors:  Victor W Henderson
Journal:  J Steroid Biochem Mol Biol       Date:  2013-05-28       Impact factor: 4.292

6.  Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback.

Authors:  Juliana M Kling; N Maritza Dowling; Heather A Bimonte-Nelson; Carey E Gleason; Kejal Kantarci; JoAnn E Manson; Hugh S Taylor; Eliot A Brinton; Rogerio A Lobo; Marcelle I Cedars; Lubna Pal; Genevieve Neal-Perry; Frederick Naftolin; S Mitchell Harman; Virginia M Miller
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-30       Impact factor: 3.619

7.  Endocrine profile of the VCD-induced perimenopausal model rat.

Authors:  Ruither O G Carolino; Paulo T Barros; Bruna Kalil; Janete Anselmo-Franci
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.